Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Predictive Oncology (POAI) Short Interest Ratio & Short Volume

Predictive Oncology logo
$0.87 0.00 (0.00%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$0.86 -0.01 (-0.57%)
As of 08/14/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Predictive Oncology Short Interest Data

Predictive Oncology (POAI) has a short interest of 126,000 shares, representing 1.25% of the float (the number of shares available for trading by the public). This marks a 13.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 217,040 shares to cover all short positions.

Current Short Interest
126,000 shares
Previous Short Interest
110,700 shares
Change Vs. Previous Month
+13.82%
Dollar Volume Sold Short
$99.41 thousand
Short Interest Ratio
0.7 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
10,220,000 shares
Float Size
10,070,000 shares
Short Percent of Float
1.25%
Today's Trading Volume
185,742 shares
Average Trading Volume
217,040 shares
Today's Volume Vs. Average
86%
Short Selling Predictive Oncology?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Predictive Oncology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

POAI Short Interest Over Time

POAI Days to Cover Over Time

POAI Percentage of Float Shorted Over Time

Predictive Oncology Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2025126,000 shares $99.41 thousand +13.8%1.3%0.7 $0.79
7/15/2025110,700 shares $87.51 thousand +64.0%1.1%0.6 $0.79
6/30/202567,500 shares $56.03 thousand -36.0%0.7%0.4 $0.83
6/15/2025105,400 shares $101.18 thousand -44.5%1.2%0 $0.96
5/31/2025189,800 shares $170.82 thousand +50.6%2.2%0.1 $0.90
5/15/2025126,000 shares $138.60 thousand -37.8%1.4%0 $1.10
4/30/2025202,700 shares $222.97 thousand -24.1%2.3%0.1 $1.10
4/15/2025267,000 shares $260.94 thousand -74.6%3.0%0.1 $0.98
3/31/20251,050,000 shares $1.60 million +165.3%11.9%0.2 $1.52
3/15/2025395,800 shares $443.30 thousand -22.7%5.6%0.1 $1.12
2/28/2025512,300 shares $712.10 thousand +10.6%7.2%0.3 $1.39
2/15/2025463,100 shares $750.22 thousand -26.1%6.5%0.2 $1.62
1/31/2025626,700 shares $921.25 thousand +36.9%9.6%0.3 $1.47
1/15/2025457,800 shares $544.78 thousand +224.2%7.0%0.2 $1.19
12/31/2024141,200 shares $115.78 thousand +7.4%2.2%0.1 $0.82
12/15/2024131,500 shares $102.56 thousand -9.4%2.0%1.3 $0.78
11/30/2024145,100 shares $116.81 thousand -9.6%2.2%1.4 $0.81
11/15/2024160,500 shares $110.20 thousand +7.7%2.5%1.5 $0.69
10/31/2024149,000 shares $106.89 thousand -7.6%2.3%1.3 $0.72
10/15/2024161,300 shares $88.73 thousand +56.8%2.5%0.1 $0.55
9/30/2024102,900 shares $81.09 thousand +60.5%1.6%0 $0.79
9/15/202464,100 shares $57.69 thousand -18.0%1.0%0 $0.90
8/31/202478,200 shares $74.76 thousand -3.6%1.2%0 $0.96
8/15/202481,100 shares $76.06 thousand -62.5%1.3%0 $0.94
7/31/2024216,400 shares $244.53 thousand +1,039.0%5.5%0.1 $1.13
7/15/202419,000 shares $21.09 thousand -63.5%0.5%0 $1.11
6/30/202452,000 shares $54.08 thousand -32.4%1.3%0 $1.04
6/15/202476,900 shares $93.82 thousand -71.1%2.0%0 $1.22
5/31/2024265,900 shares $380.24 thousand +121.0%6.7%0.2 $1.43
5/15/2024120,300 shares $209.32 thousand +484.0%3.1%0.7 $1.74
4/30/202420,600 shares $29.46 thousand +58.5%0.5%0.1 $1.43
4/15/202413,000 shares $19.63 thousand -49.0%0.3%0.4 $1.51
3/31/202425,500 shares $65.03 thousand +129.7%0.7%1.1 $2.55
3/15/202411,100 shares $29.30 thousand -37.6%0.3%0.5 $2.64
2/29/202417,800 shares $54.82 thousand -31.5%0.5%0.9 $3.08
2/15/202426,000 shares $84.50 thousand -19.3%0.7%1.3 $3.25
1/31/202432,200 shares $98.85 thousand -8.3%0.8%1.9 $3.07
1/15/202435,100 shares $101.09 thousand -33.7%0.9%1.9 $2.88
12/31/202352,900 shares $174.04 thousand -15.5%1.4%2.9 $3.29
12/15/202362,600 shares $197.82 thousand -26.4%1.6%3.6 $3.16
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
11/30/202385,000 shares $277.95 thousand -13.6%2.2%4.5 $3.27
11/15/202398,400 shares $306.02 thousand -4.7%2.5%4.9 $3.11
10/31/2023103,200 shares $309.60 thousand -13.5%2.7%4.3 $3.00
10/15/2023119,300 shares $472.43 thousand -5.5%3.1%3.9 $3.96
9/30/2023126,300 shares $404.16 thousand -32.1%3.2%2.7 $3.20
9/15/2023186,000 shares $597.06 thousand -29.7%4.8%2.4 $3.21
8/31/2023264,400 shares $1.14 million -7.8%6.8%2.7 $4.32
8/15/2023286,900 shares $1.37 million -4.9%7.4%2.4 $4.76
7/31/2023301,700 shares $1.75 million -0.5%7.8%2.1 $5.80
7/15/2023303,200 shares $1.77 million +16.3%7.8%1.5 $5.84
6/30/2023260,800 shares $1.27 million +123.7%6.7%1.1 $4.86
6/15/2023116,600 shares $402.27 thousand -11.1%3.0%0.5 $3.45
5/31/2023131,100 shares $423.45 thousand +40.7%3.4%0.7 $3.23
5/15/202393,200 shares $318.74 thousand -49.1%2.5%0.6 $3.42
4/30/2023183,100 shares $520.00 thousand +421.7%4.9%1.3 $2.84
4/15/202335,100 shares $266.76 thousand -84.3%N/A0.3 $7.60
3/31/2023223,500 shares $73.04 thousand +6.9%N/A0.5 $0.33
3/15/2023209,000 shares $68.97 thousand -25.3%N/A0.5 $0.33
2/28/2023279,600 shares $119.11 thousand +17.1%N/A0.7 $0.43
2/15/2023238,800 shares $103.64 thousand -42.8%N/A0.6 $0.43
1/31/2023417,100 shares $221.06 thousand +64.0%N/A1 $0.53
1/15/2023254,300 shares $122.70 thousand +14.2%N/A0.7 $0.48
12/30/2022222,700 shares $68.28 thousand -4.6%N/A0.7 $0.31
12/15/2022233,500 shares $94.01 thousand +89.7%N/A0.7 $0.40
11/30/2022123,100 shares $47.41 thousand +68.9%N/A0.4 $0.39
11/15/202272,900 shares $19.87 thousand -63.7%N/A0.3 $0.27
10/31/2022201,000 shares $54.77 thousand +50.9%N/A0.8 $0.27
10/15/2022133,200 shares $40.64 thousand -32.4%N/A0.6 $0.31
9/30/2022196,900 shares $70.88 thousand +6.4%N/A0.7 $0.36
9/15/2022185,100 shares $71.30 thousand +10.4%N/A0.6 $0.39
8/31/2022167,600 shares $67.58 thousand -5.6%N/A0.5 $0.40
8/15/2022177,600 shares $77.27 thousand -10.6%N/A0.2 $0.44
7/31/2022198,700 shares $81.55 thousand -11.9%N/A0.2 $0.41
7/15/2022225,600 shares $94.75 thousand -5.9%N/A0.2 $0.42
6/30/2022239,800 shares $98.34 thousand +29.5%N/A0.2 $0.41
6/15/2022185,200 shares $72.36 thousand -63.2%N/A0.2 $0.39
5/31/2022502,900 shares $184.31 thousand -32.1%N/A0.5 $0.37
5/15/2022740,700 shares $517.68 thousand +1.7%N/A0.8 $0.70
4/30/2022728,000 shares $526.34 thousand +4.8%N/A2.3 $0.72
4/15/2022694,500 shares $541.02 thousand -25.9%N/A1.9 $0.78
3/31/2022936,800 shares $915.25 thousand -13.3%N/A2.1 $0.98
3/15/20221,080,000 shares $993.60 thousand +6.9%N/A2.5 $0.92
2/28/20221,010,000 shares $791.44 thousand -4.7%N/A2.2 $0.78
2/15/20221,060,000 shares $826.80 thousand -26.9%N/A2 $0.78
1/31/20221,450,000 shares $1.28 million +39.4%N/A2.4 $0.88
1/15/20221,040,000 shares $926.54 thousand -1.0%N/A1.5 $0.89
12/31/20211,050,000 shares $999.50 thousand -18.6%N/A1.5 $0.95
12/15/20211,290,000 shares $1.26 million +14.2%N/A1 $0.98
11/30/20211,130,000 shares $1.16 million +9.7%N/A0.6 $1.03
11/15/20211,030,000 shares $1.19 million +2.0%N/A0.6 $1.16
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/29/20211,010,000 shares $1.27 million -30.8%N/A0.5 $1.26
10/15/20211,460,000 shares $1.77 million +1.4%N/A0.8 $1.21
9/30/20211,440,000 shares $1.92 million -8.9%N/A0.7 $1.33
9/15/20211,580,000 shares $1.56 million -15.5%N/A0.7 $0.99
8/31/20211,870,000 shares $2.00 million +0.5%N/A0.7 $1.07
8/13/20211,860,000 shares $1.92 million +35.8%N/A0.7 $1.03
7/30/20211,370,000 shares $1.55 million -9.3%N/A0.5 $1.13
7/15/20211,510,000 shares $1.81 million +2.0%N/A0.5 $1.20
6/30/20211,480,000 shares $1.94 million -32.1%N/A0.5 $1.31
6/15/20212,180,000 shares $2.25 million -37.7%4.8%0.8 $1.03
5/28/20213,500,000 shares $4.13 million -20.8%7.7%1.5 $1.18
5/14/20214,420,000 shares $3.71 million -6.8%N/A1.6 $0.84
4/30/20214,740,000 shares $5.31 million +69.9%N/A1.2 $1.12
4/15/20212,790,000 shares $3.29 million -8.8%N/A0.6 $1.18
3/31/20213,060,000 shares $3.43 million -15.9%N/A0.6 $1.12
3/15/20213,640,000 shares $6.08 million -2.4%N/A0.8 $1.67
2/26/20213,730,000 shares $5.48 million +326.7%N/A0.9 $1.47
2/12/2021874,100 shares $1.62 million +20.6%N/A0.2 $1.85
1/29/2021724,900 shares $855.38 thousand -5.8%2.7%0.3 $1.18
1/15/2021769,100 shares $714.19 thousand +79.6%2.9%0.4 $0.93
12/31/2020428,200 shares $298.41 thousand +58.6%2.8%0.4 $0.70
12/15/2020270,000 shares $195.75 thousand -14.6%1.7%0.4 $0.73
11/30/2020316,000 shares $233.84 thousand -7.9%2.1%0.3 $0.74
11/15/2020343,200 shares $239.52 thousand -38.1%2.2%0.3 $0.70
10/30/2020554,400 shares $398.61 thousand +44.2%4.2%0.5 $0.72
10/15/2020384,600 shares $305.33 thousand +24.3%2.9%0.3 $0.79
9/30/2020309,400 shares $251.88 thousand -19.1%2.4%0.2 $0.81
9/15/2020382,400 shares $328.86 thousand +36.5%2.9%0.3 $0.86
8/31/2020280,200 shares $302.62 thousand +4.5%2.2%0.3 $1.08

POAI Short Interest - Frequently Asked Questions

What is Predictive Oncology's current short interest?

Short interest is the volume of Predictive Oncology shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 126,000 shares of POAI short. 1.25% of Predictive Oncology's shares are currently sold short. Learn More on Predictive Oncology's current short interest.

What is a good short interest ratio for Predictive Oncology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. POAI shares currently have a short interest ratio of 1.0. Learn More on Predictive Oncology's short interest ratio.

What is a good short interest percentage for Predictive Oncology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.25% of Predictive Oncology's floating shares are currently sold short.

Is Predictive Oncology's short interest increasing or decreasing?

Predictive Oncology saw a increase in short interest in July. As of July 31st, there was short interest totaling 126,000 shares, an increase of 13.8% from the previous total of 110,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Predictive Oncology's float size?

Predictive Oncology currently has issued a total of 10,220,000 shares. Some of Predictive Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Predictive Oncology currently has a public float of 10,070,000 shares.

How does Predictive Oncology's short interest compare to its competitors?

1.25% of Predictive Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Predictive Oncology: Envoy Medical, Inc. (0.90%), Vivos Therapeutics, Inc. (7.89%), CollPlant Biotechnologies Ltd. Sponsored ADR (1.09%), Femasys Inc. (1.41%), DarioHealth Corp. (7.52%), Retractable Technologies, Inc. (0.27%), IRIDEX Corporation (2.38%), Allurion Technologies, Inc. (1.79%), NexGel, Inc. (0.53%), NeurAxis, Inc. (0.64%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Predictive Oncology stock?

Short selling POAI is an investing strategy that aims to generate trading profit from Predictive Oncology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Predictive Oncology?

A short squeeze for Predictive Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of POAI, which in turn drives the price of the stock up even further.

How often is Predictive Oncology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including POAI, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:POAI) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored